Biomednewsbreaks - Roth Capital Partners With IBN As Official Media Sponsor Of Annual Roth Healthcare Opportunities Conference

(MENAFN- Investor Brand Network) Roth Capital Partners (Roth MKM), a relationship-driven investment bank dedicated to serving growth companies and their investors, is partnering with IBN as an official media sponsor for this week's third annual Roth Healthcare Opportunities Conference. The invitation-only, one-day conference is scheduled for Oct. 9, 2024, in New York City. According to the announcement, IBN will leverage its extensive corporate communications Network to increase awareness of the conference, which is an exclusive platform that gathers together veteran investors with C-suite executives from public and private companies in the healthcare sector.

“ROTH's upcoming conference is set to showcase some of the most promising innovations in the healthcare sector,” said IBN director of global operations Randy Clark in the press release.“Our ongoing partnership with ROTH allows us to leverage our comprehensive communications capabilities, helping industry stakeholders stay informed and engaged. We're excited to work closely with ROTH's outstanding team to support this event.”

To find out more about the conference, visit

To view the full press release, visit

About Roth Capital Partners
LLC

Roth Capital Partners is a relationship-driven investment bank focused on serving growth companies and their investors. As a full-service investment bank, Roth provides capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory and corporate access. Headquartered in Newport Beach, California, Roth is a privately held, employee-owned organization that maintains offices throughout the United States. For more information about this company, please visit
.

About BioMedWire

BioMedWire
(“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:
/Disclaimer

BioMedWire
San Francisco, CA

415.949.5050 Office
[email protected]

BioMedWire is powered by
IBN

MENAFN07102024000224011066ID1108755636